Inhibition of brain enzymes involved in cerebral amyloid angiopathy and macular degeneration

Details for Australian Patent Application No. 2007329539 (hide)

Owner Loma Linda University Medical Center Stony Brook University George Mason University The Regents of the University of California

Inventors Liotta, Lance A.; Kirsch, Wolff; Vinters, Harry V.; Van Nostrand, William E.; Espina, Virginia

Agent FB Rice

Pub. Number AU-A-2007329539

PCT Pub. Number WO2008/070579

Priority 60/872,275 01.12.06 US; 60/889,521 12.02.07 US

Filing date 30 November 2007

Wipo publication date 12 June 2008

International Classifications

C12N 15/11 (2006.01) Mutation or genetic engineering - DNA or RNA fragments

A61K 31/409 (2006.01) - having four such rings, e.g. porphine derivatives, bilirubin, biliverdine

A61K 31/713 (2006.01) - Double-stranded nucleic acids or oligonucleotides

A61P 25/28 (2006.01) Drugs for disorders of the nervous system

A61P 27/00 (2006.01) Drugs for disorders of the senses

Event Publications

25 June 2009 PCT application entered the National Phase

  PCT publication WO2008/070579 Priority application(s): WO2008/070579

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007329540-Software-based quality control analysis of well log data

2007329531-Vesicles of self-assembling block copolymers and methods for making and using the same